Fidelity Investments’s RxSight RXST Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$139K Buy
28,921
+19,574
+209% +$118K ﹤0.01% 3828
2026
Q1
$57.6K Sell
9,347
-19,280
-67% -$160K ﹤0.01% 4065
2025
Q4
$298K Buy
28,627
+7,145
+33% +$71.7K ﹤0.01% 3274
2025
Q3
$193K Sell
21,482
-135,655
-86% -$1.19M ﹤0.01% 3357
2025
Q2
$2.04M Sell
157,137
-876,617
-85% -$13.2M ﹤0.01% 2484
2025
Q1
$26.1M Sell
1,033,754
-60,022
-5% -$1.78M ﹤0.01% 1592
2024
Q4
$37.6M Sell
1,093,776
-108,475
-9% -$4.89M ﹤0.01% 1497
2024
Q3
$59.4M Sell
1,202,251
-52,078
-4% -$2.67M ﹤0.01% 1304
2024
Q2
$75.5M Sell
1,254,329
-64,832
-5% -$3.7M ﹤0.01% 1153
2024
Q1
$68M Buy
1,319,161
+132,684
+11% +$6.51M ﹤0.01% 1205
2023
Q4
$47.8M Buy
1,186,477
+1,185,612
+137,065% +$34.8M ﹤0.01% 1310
2023
Q3
$24.1K Buy
865
+91
+12% +$2.71K ﹤0.01% 3712
2023
Q2
$22.3K Buy
774
+47
+6% +$1.04K ﹤0.01% 3808
2023
Q1
$12.1K Buy
727
+401
+123% +$5.66K ﹤0.01% 4052
2022
Q4
$4.13K Buy
326
+129
+65% +$1.57K ﹤0.01% 4315
2022
Q3
$2K Buy
197
+1
+0.5% +$14 ﹤0.01% 4585
2022
Q2
$3K Buy
196
+87
+80% +$1.15K ﹤0.01% 4485
2022
Q1
$1K Buy
+109
New +$1.31K ﹤0.01% 4841

Other funds holding RXST

Fidelity Investments's RXST Position: Q2 2026 in Review

Fidelity Investments increased its RxSight (RXST) stake by 209% in Q2 2026, buying an estimated $118K and bringing the position to 28,921 shares worth $139K. The position accounts for ﹤0.01% of the portfolio, ranked #3828.

Fidelity Investments first reported a position in RXST in Q1 2022 and has held it in 18 quarters since. The position peaked at $75.5M in Q2 2024. 150 funds tracked by Wall St. Rank hold RXST as of Q2 2026.

  • Fidelity Investments held 28,921 shares of RxSight worth $139K as of Q2 2026.
  • Fidelity Investments bought 19,574 RxSight shares in Q2 2026, an estimated $118K.
  • RxSight made up ﹤0.01% of Fidelity Investments's portfolio in Q2 2026, its #3828 holding.
  • Fidelity Investments first reported a position in RxSight in Q1 2022 and has held it in 18 quarters since.
  • Fidelity Investments's RxSight position peaked at $75.5M in Q2 2024.
  • 150 funds tracked by Wall St. Rank held RxSight as of Q2 2026.

Based on Fidelity Investments's 13F filing for Q2 2026, filed 13 Aug 2026.